期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Efficacy and safety of immunosuppressive therapy for autoimmune hepatitis patients with cirrhosis unsuitable for biopsy
1
作者 Lin Wang Dong-Ying Ji Ji-Dong Jia 《Hepatobiliary & Pancreatic Diseases International》 2025年第5期570-575,共6页
To the Editor:Autoimmune hepatitis(AIH)is an immune-mediated chronic liver disease that can progress to cirrhosis and even liver failure.The standard treatment approach for AIH involves the adminis-tration of immunosu... To the Editor:Autoimmune hepatitis(AIH)is an immune-mediated chronic liver disease that can progress to cirrhosis and even liver failure.The standard treatment approach for AIH involves the adminis-tration of immunosuppressive therapy,utilizing corticosteroids and azathioprine(Imuran),which result in clinical and histological im-provement among 60%AIH patients[1,2].The diagnosis of AIH requires a combination of clinical,bio-chemical,and histological findings.The first diagnostic system was established in 1993[3],revised in 1999[4],and then a simplified criterion was proposed[5].Liver histology plays an important role in the scoring systems of AIH diagnosis and is essential to make an accurate diagnosis.Due to the lack of obvious symptoms in the early stage,about 30%patients have already progressed to cirrho-sis by the time of diagnosis[6]. 展开更多
关键词 liver failurethe immunosuppressive therapy clinical improvement immunosuppressive therapyutilizing autoimmune hepatitis diagnostic system BIOPSY chronic liver disease
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部